Copyright
©The Author(s) 2021.
World J Gastroenterol. May 14, 2021; 27(18): 2090-2104
Published online May 14, 2021. doi: 10.3748/wjg.v27.i18.2090
Published online May 14, 2021. doi: 10.3748/wjg.v27.i18.2090
Table 3 Hepatitis E virus-related neurological manifestations
Diseases | n (%) | Geographic distribution | Mean age in yr | M:F ratio | Serological diagnosis | Serum HEV-RNA | Genotype | CSF HEV-RNA | Elevated bilirubin, n | Median (range) ALT in IU/L | Use of anti-viral | Recovery |
Nerve root and plexus disorders | ||||||||||||
Neuralgic amyotrophy[13,15-17,28-56] | 64 (39) | Europe: 62; SEAR: 1; United States: 1 | 45.7 | 6.5:1 | 51 | 44 | GT3: 28 | 0 | 4 | 1007 (22-2579) | 9 | CR: 9; PR: 47; NM: 8 |
Guillain-Barré syndrome[13,15,16,20,36,58-85] | 61 (37) | SEAR: 21; Europe: 30; China/Hong Kong: 5; Japan: 4; Iraq: 1 | 51.16 | 2.42:1 | 46 | 20 | GT3: 10; GT4: 1; GT1: 2 | 3 | 11 | 1950 (57-4502) | 1 | CR: 23; PR: 14; Died: 1; NM: 23 |
Central nervous system disorder | ||||||||||||
Meningoencephalitis[17,20,35,86,87] | 6 (4) | Europe: 2; China: 2; SEAR: 1; United States: 1 | 44 | 1:1 | 6 | 5 | GT 3: 2 | 2 | 0 | 142 (20-479) | 1 | CR: 5; NM: 1 |
Cerebral ischemia[17,20] | 5 (3) | Europe: 3; China: 2 | 66 | 4:1 | 5 | 4 | GT3: 2 | 0 | 0 | 18 (8-28) | 0 | CR: 3; PR: 2 |
Seizures[17] | 2 (1) | Europe | 71 | 1:1 | 2 | 1 | GT3: 1 | 0 | 0 | 19 (10-28) | 0 | CR: 2 |
Transverse myelitis[88] | 1 (0.6) | Europe | 62 | 0:1 | 1 | 1 | GT3: 1 | 1 | 0 | 1152 | 0 | PR: 1 |
Neuropathy | ||||||||||||
Mononeuritis multiplex[36] | 6 (4) | Europe | 53.16 | 1:1 | 6 | 4 | GT3: 3 | 0 | 1 | 188 (118-3641) | 1 | CR: 5; PR: 1 |
Peripheral neuropathy[16,20,89] | 5 (3) | Europe: 4; China: 1 | 57.4 | 3:2 | 5 | 5 | GT3: 2 | 2 | 1 | 285 (30-1606) | 1 | CR: 2; PR: 3 |
Cranial neuropathy | ||||||||||||
Cranial neuropathy[16,17,90-92] | 5 (3) | SEAR: 2; Europe: 2; Japan: 1 | 53 | 4:1 | 2 | 2 | GT3: 1; GT4: 3; ND | 0 | 0 | 1200 (60-3866) | 0 | CR: 5 |
Neuromuscular junction and muscle disorders | ||||||||||||
Myositis[93] | 1 (0.6) | Europe | 57 | 1:0 | 1 | 1 | ND | 0 | 1 | 1030 | 1 | CR:1 |
Myasthenia gravis[18] | 1 (0.6) | Europe | 33 | 0:1 | 1 | 1 | GT3: 1 | 0 | 0 | 190 | 1 | NM: 1 |
Others neurological disorders | ||||||||||||
Meningoradiculitis[36,94,95] | 6 (4) | Europe | 53.33 | 1:1 | 6 | 6 | GT3: 5 | 4 | 1 | 406 (40-822) | 1 | CR: 5; Died: 1 |
Total cases, n (%) | ||||||||||||
Total | 163 | Europe: 120 (74); WHO SEAR: 25 (15); China/Hong Kong: 10 (6), Japan: 4; United States: 2; Iraq: 1 | 53.9 | 2.84:1 | 132 (81) | 94 (58) | GT3: 56 (90); GT4: 4; GT1: 2 | 12 (7) | 19 (12) | 345.5 (16-4502) | Ribavirin: 16 (10) | CR: 60 (46); PR: 68 (53) Died:2; NM 33 (20) |
- Citation: Jha AK, Kumar G, Dayal VM, Ranjan A, Suchismita A. Neurological manifestations of hepatitis E virus infection: An overview. World J Gastroenterol 2021; 27(18): 2090-2104
- URL: https://www.wjgnet.com/1007-9327/full/v27/i18/2090.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i18.2090